Market research
092730.KO Neopharm Co Ltd
KO KRW Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the 092730.KO discussion.
5 years, 5 months ago
Neopharm Co Ltd is currently in a long term uptrend where the price is trading 8.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Neopharm Co Ltd's total revenue rose by 0.9% to $23B since the same quarter in the previous year.
Its net income has dropped by 10.3% to $5B since the same quarter in the previous year.
Finally, its free cash flow fell by 4.5% to $8B since the same quarter in the previous year.
Based on the above factors, Neopharm Co Ltd gets an overall score of 3/5.